2802 Phase II study of first-line paclitaxel (PTX) with panitumumab (P) in patients with metastatic or recurrent head and neck cancer: TTCC-2009-03 study. (September 2015) - Del Barco Morillo, E.; Mesia, R.; Adansa Klain, J.C.; Fernández, S. Vazquez; Galan, J. Martínez; Borgoñnon, M. Pastor; Rivas, C. González; Caballero Daroqui, J.; Berrocal, A.; Trufero, J. Martínez; Cruz Hernández, J.J.; Vera, R.